Literature DB >> 19342097

Effect of oxidative stress on birth sizes: consideration of window from mid pregnancy to delivery.

J Min1, B Park, Y J Kim, H Lee, E Ha, H Park.   

Abstract

The aims of this study were to determine (1) whether the urinary mid pregnancy and placental delivery oxidative stress levels are related to the intrauterine condition and (2) whether long-lasting adverse oxidative stress is related to the birth size. We investigated pregnant women when they were at 24-28 weeks of pregnancy from October 2001 to May 2003 and at their delivery. Samples were obtained at each investigation time. Other information of mothers and their birth records were tracked from medical charts at Ewha Womans University Hospital in Seoul, South Korea. We quantified mid pregnancy oxidative stress by measuring urinary levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) in 272 subjects. Intrauterine oxidative stress at delivery was measured by placental levels of 8-OHdG and MDA in 54 and 38 subjects, respectively. To identify the correlated intrauterine oxidative stress conditions, we evaluated kappa statistics and Pearson's correlations between maternal and placental oxidative stress. The relationships between intrauterine oxidative stress and birth sizes were examined by a general linear model. The levels of oxidative stress were divided to two groups based on their 75th percentile values. There was no correlation between urinary mid pregnancy and placental delivery oxidative stress levels for both MDA (kappa index=0.32, r=0.21) and 8-OHdG (kappa index=-0.13, r=-0.11). Both the urinary mid pregnancy and delivery 8-OHdG levels were significantly related to birth size. The birth size was largest in the 8-OHdG group. In addition, birth size was worse in the group with both high urinary mid pregnancy and placental oxidative stress than in any other combinations of low and high groups of urinary mid pregnancy and placental delivery oxidative stress. This evidence for a weak correlation between urinary mid pregnancy and placental delivery oxidative stress levels and its interactive effects on birth size suggest that the period from the middle to the end of pregnancy is critical window to intrauterine growth and also represents a modifiable period of the intrauterine condition. Therefore, applying interventions to pregnant women with high oxidative stress levels at midterm could contribute to increasing birth sizes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342097     DOI: 10.1016/j.placenta.2009.02.007

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  13 in total

1.  Oxidative DNA damage in early pregnancy and risk of gestational diabetes mellitus: A pilot study.

Authors:  Chunfang Qiu; Karin Hevner; Dejene Abetew; Daniel A Enquobahrie; Michelle A Williams
Journal:  Clin Biochem       Date:  2011-05-13       Impact factor: 3.281

2.  Maternal exposure to selenium and cadmium, fetal growth, and placental expression of steroidogenic and apoptotic genes.

Authors:  Todd M Everson; Maya Kappil; Ke Hao; Brian P Jackson; Tracy Punshon; Margaret R Karagas; Jia Chen; Carmen J Marsit
Journal:  Environ Res       Date:  2017-07-03       Impact factor: 6.498

3.  The Paraoxonase 1 Arylesterase Activity, Total Oxidative Stress, Nitric Oxide and Vitamin C Levels in Maternal Serum, and Their Relation to Birth Weight of Newborn.

Authors:  Mukund Ramchandra Mogarekar; Mahendra G Dhabe; Chanchal C Gujrathi
Journal:  J Obstet Gynaecol India       Date:  2015-05-16

4.  Mitochondrial DNA copy number and oxidative DNA damage in placental tissues from gestational diabetes and control pregnancies: a pilot study.

Authors:  Chunfang Qiu; Karin Hevner; Dejene Abetew; Margaret Sedensky; Philip Morgan; Daniel A Enquobahrie; Michelle A Williams
Journal:  Clin Lab       Date:  2013       Impact factor: 1.138

5.  Lipid-lysine adducts and modified tyrosines as markers of oxidative stress in the second trimester of pregnancy and their association with infant characteristics.

Authors:  Barbara Rejc; Yoji Kato; Natasa Karas-Kuzelicki; Josko Osredkar; Ksenija Gersak
Journal:  Exp Ther Med       Date:  2016-01-12       Impact factor: 2.447

6.  Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature.

Authors:  Emily K Hayes; Anna Lechowicz; Jim J Petrik; Yaryna Storozhuk; Sabrina Paez-Parent; Qin Dai; Imtiaz A Samjoo; Margaret Mansell; Andree Gruslin; Alison C Holloway; Sandeep Raha
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

7.  Urinary metabolites of polycyclic aromatic hydrocarbons in pregnant women and their association with a biomarker of oxidative stress.

Authors:  Xiang-Yin Lou; Peng-Ran Wu; Ying Guo
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-19       Impact factor: 5.190

8.  Placental Cadmium Levels Are Associated with Increased Preeclampsia Risk.

Authors:  Jessica E Laine; Paul Ray; Wanda Bodnar; Peter H Cable; Kim Boggess; Steven Offenbacher; Rebecca C Fry
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

9.  Key Clinical Factors Predicting Adipokine and Oxidative Stress Marker Concentrations among Normal, Overweight and Obese Pregnant Women Using Artificial Neural Networks.

Authors:  Mario Solis-Paredes; Guadalupe Estrada-Gutierrez; Otilia Perichart-Perera; Araceli Montoya-Estrada; Mario Guzmán-Huerta; Héctor Borboa-Olivares; Eyerahi Bravo-Flores; Arturo Cardona-Pérez; Veronica Zaga-Clavellina; Ethel Garcia-Latorre; Gabriela Gonzalez-Perez; José Alfredo Hernández-Pérez; Claudine Irles
Journal:  Int J Mol Sci       Date:  2017-12-28       Impact factor: 5.923

10.  Thioredoxin-1 and oxidative stress status in pregnant women at early third trimester of pregnancy: relation to maternal and neonatal characteristics.

Authors:  Yoko Nakatsukasa; Hirokazu Tsukahara; Kazuhisa Tabuchi; Masako Tabuchi; Tomoko Magami; Mutsuko Yamada; Yosuke Fujii; Masato Yashiro; Mitsuru Tsuge; Tsuneo Morishima
Journal:  J Clin Biochem Nutr       Date:  2012-10-24       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.